April 11, 2023
Drugmaker Mallinckrodt PLC Tuesday asked a Delaware bankruptcy judge to rule that the Chapter 11 plan he approved for the company last year releases it from a lawsuit over nuclear waste it produced 80 years ago as a contractor on the Manhattan Project.
December 08, 2022
The Texas Office of the Attorney General told a Delaware bankruptcy judge Thursday it may ask him to rule against a request to pay attorney fees in Texas opioid multidistrict litigation out of the opioid claims trust established in the Mallinckrodt Chapter 11 plan.
October 21, 2022
Navient Solutions is appealing a nationwide injunction barring it from collecting on certain student loans discharged through bankruptcy, Mallinckrodt creditors are suing for the return of $1.6 billion used to buy back shares pre-bankruptcy, and liquidators for crypto hedge fund Three Arrows Capital want to serve subpoenas via Twitter. This is the week in bankruptcy.
October 18, 2022
A litigation trust formed under opioid distributor Mallinckrodt PLC's now-confirmed Delaware Chapter 11 has sued to claw back proceeds from nearly $1.6 billion in pre-bankruptcy share repurchases, carried out as the company's liability for the opioid epidemic swamped its total worth.
October 14, 2022
Conspiracy theorist Alex Jones' podcast company is headed toward Chapter 11 mediation after a $965 million defamation damages judgment, Puerto Rico takes another step in restructuring the island's public debt, and the U.S. Supreme Court remanded issues over an increase in trustee fees to the Second Circuit. This is the week in bankruptcy.
October 13, 2022
The trustee administering the claims of general unsecured creditors under the confirmed plan of drugmaker Mallinckrodt PLC asked a Delaware bankruptcy court for approval Wednesday of a settlement that would resolve royalty claims associated with the company's Acthar gel.
June 08, 2022
Bankrupt drugmaker Mallinckrodt PLC reported Wednesday that its Chapter 11 plan would most likely take effect on June 14, after the eleventh-hour approval of a $650 million exit financing package that replaced — at much higher cost — a $900 million exit financing agreement.
May 23, 2022
Drugmaker Mallinckrodt PLC objected Monday to a motion from an equity holder seeking to stay the consummation of the company's Chapter 11 plan pending the outcome of an appeal of a claims bar date decision, saying the stay motion came months late and after other, more targeted stay requests were defeated.
April 25, 2022
Unsecured creditors of drugmaker Mallinckrodt PLC have lost their bid to delay the effective date of the company's Chapter 11 plan in Delaware federal court, with a Third Circuit judge saying the creditors had not shown they would be irreparably harmed if the plan is consummated.
March 24, 2022
A Delaware bankruptcy judge Thursday denied requests to hold distributions from drugmaker Mallinckrodt's Chapter 11 plan while appeals of how the funds are being divided up are pending, saying it is likely the appeals will be heard before the money goes out.